United States - English - NLM (National Library of Medicine)

proficient rx lp - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - thyroid hormone drugs are indicated: liothyronine sodium tablets can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis and apparent hypersensitivity to any of their active or extraneous constituents. there is no well-documented evidence from the literature, however, of true allergic or idiosyncratic reactions to thyroid hormone.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - liothyronine sodium - powder for solution for injection - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - liothyronine sodium - oral tablet - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - liothyronine sodium - oral tablet - 20microgram

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine sodium tablets, usp are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. liothyronine sodium tablets, usp are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. liothyronine sodium tablets, usp are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. limitations of use - liothyronine sodium tablets, usp are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium tablets, usp may induce hyperthyroidism [see warnings and precautions (5.4)]. - liothyronine sodium tablets, usp are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. liothyronine sodiu